Enlivex Therapeutics Ltd. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Enlivex Therapeutics Ltd. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Enlivex Therapeutics Ltd. Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.99M, a 55.1% increase year-over-year.
  • Enlivex Therapeutics Ltd. annual Operating Income (Loss) for 2023 was -$29.4M, a 13.9% decline from 2022.
  • Enlivex Therapeutics Ltd. annual Operating Income (Loss) for 2022 was -$25.8M, a 33.7% decline from 2021.
  • Enlivex Therapeutics Ltd. annual Operating Income (Loss) for 2021 was -$19.3M, a 97.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$29.4M -$3.6M -13.9% Jan 1, 2023 Dec 31, 2023 20-F 2024-04-30
2022 -$25.8M -$6.51M -33.7% Jan 1, 2022 Dec 31, 2022 20-F 2024-04-30
2021 -$19.3M -$9.5M -97.1% Jan 1, 2021 Dec 31, 2021 20-F 2024-04-30
2020 -$9.79M -$1.17M -13.5% Jan 1, 2020 Dec 31, 2020 20-F 2023-04-10
2019 -$8.62M -$3.32M -62.7% Jan 1, 2019 Dec 31, 2019 20-F 2022-04-29
2018 -$5.3M -$3.13M -144% Jan 1, 2018 Dec 31, 2018 20-F 2021-04-30
2017 -$2.17M +$13.7M +86.3% Jan 1, 2017 Dec 31, 2017 20-F 2020-04-30
2016 -$15.9M -$390K -2.52% Jan 1, 2016 Dec 31, 2016 20-F/A 2020-01-23
2015 -$15.5M -$8.4M -119% Jan 1, 2015 Dec 31, 2015 20-F 2018-04-23
2014 -$7.08M -$5.93M -517% Jan 1, 2014 Dec 31, 2014 20-F 2017-02-24
2013 -$1.15M -$922K -408% Jan 1, 2013 Dec 31, 2013 20-F 2016-03-29
2012 -$226K Jan 1, 2012 Dec 31, 2012 20-F 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.